Background The incidence of adrenal incidentalomas (AIs) is increasing yearly. The early discovery of AIs is helpful to better manage adrenal diseases, especially subclinical primary aldosteronism, Cushing's syndrome and pheochromocytoma.
Xie et al. (Thu,) studied this question.